Alembic Pharmaceuticals consolidated net profit rises 143.66% in the June 2020 quarter

Bs_logoImage
Capital Market
Last Updated : Jul 23 2020 | 9:06 AM IST

Sales rise 41.35% to Rs 1341.32 crore

Net profit of Alembic Pharmaceuticals rose 143.66% to Rs 301.46 crore in the quarter ended June 2020 as against Rs 123.72 crore during the previous quarter ended June 2019. Sales rose 41.35% to Rs 1341.32 crore in the quarter ended June 2020 as against Rs 948.91 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales1341.32948.91 41 OPM %30.3723.70 -PBDT401.00223.22 80 PBT359.50187.82 91 NP301.46123.72 144

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 23 2020 | 8:54 AM IST